BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28120343)

  • 1. The distinctive cytological features of T-cell prolymphocytic leukemia.
    Jayakar V; Cheung K; Yebra-Fernandez E; Bain BJ
    Am J Hematol; 2017 Aug; 92(8):830-832. PubMed ID: 28120343
    [No Abstract]   [Full Text] [Related]  

  • 2. Array comparative genomic hybridization in the detection of chromosomal abnormalities in T-cell prolymphocytic leukemia.
    Urbánková H; Holzerová M; Balcárková J; Raida L; Procházka V; Pikalová Z; Papajík T; Indrák K; Jarosová M
    Cancer Genet Cytogenet; 2010 Oct; 202(1):58-62. PubMed ID: 20804923
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cerebriform variant type of T cell prolymphocytic leukemia: Report of one case].
    Peña C; Valladares X; Soto C; Encina A; Marinov N; Undurraga MS; Cabrera ME
    Rev Med Chil; 2016 Jan; 144(1):124-8. PubMed ID: 26998991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined immunophenotyping and karyotyping in peripheral T cell lymphomas demonstrating different clonal and nonclonal chromosome aberrations in T helper cells.
    Schlegelberger B; Weber-Matthiesen K; Sterry W; Bartels H; Sonnen R; Maschmeyer G; Feller AC; Grote W
    Leuk Lymphoma; 1994 Sep; 15(1-2):113-25. PubMed ID: 7858488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.
    Magro CM; Morrison CD; Heerema N; Porcu P; Sroa N; Deng AC
    J Am Acad Dermatol; 2006 Sep; 55(3):467-77. PubMed ID: 16908353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [T-cell prolymphocytic leukemia: potential diagnostic pitfalls].
    Dessart P; Lemaire P; Le Dû K; Sandrini J; Prophette B; Maillard H
    Ann Dermatol Venereol; 2014 Dec; 141(12):777-81. PubMed ID: 25433931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A T-lineage neoplasm-Which one?
    Bain BJ; Fawcett N
    Am J Hematol; 2009 Oct; 84(10):678. PubMed ID: 19373891
    [No Abstract]   [Full Text] [Related]  

  • 8. T-cell prolymphocytic leukemia with a novel translocation (6;11)(q21;q23).
    Wong KF; Chan JK; Sin VC
    Cancer Genet Cytogenet; 1999 Jun; 111(2):149-51. PubMed ID: 10347553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Study Interpretation--Houston: Case 4. T-cell prolymphocytic leukemia.
    Al-Quran SZ
    Cytometry B Clin Cytom; 2011; 80(4):264-8. PubMed ID: 21638771
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic significance of cytogenetic abnormalities in T-cell prolymphocytic leukemia.
    Hu Z; Medeiros LJ; Fang L; Sun Y; Tang Z; Tang G; Sun T; Quesada AE; Hu S; Wang SA; Pei L; Lu X
    Am J Hematol; 2017 May; 92(5):441-447. PubMed ID: 28194886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-Cell Prolymphocytic Leukemia, Small Cell Variant, Possibly at the Stage of Intracytoplasmic Expression of CD3 in T-Cell Ontogenesis.
    Yoshioka Y; Nagao M; Saitoh T; Yoshioka S; Tsunemine H; Itoh K; Kodaka T; Takahashi T
    J Clin Exp Hematop; 2015; 55(1):17-21. PubMed ID: 26106002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunophenotypic characterization of T-cell prolymphocytic leukemia.
    Chen X; Cherian S
    Am J Clin Pathol; 2013 Nov; 140(5):727-35. PubMed ID: 24124154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia.
    Staber PB; Herling M; Bellido M; Jacobsen ED; Davids MS; Kadia TM; Shustov A; Tournilhac O; Bachy E; Zaja F; Porkka K; Hoermann G; Simonitsch-Klupp I; Haferlach C; Kubicek S; Mayerhoefer ME; Hopfinger G; Jaeger U; Dearden C
    Blood; 2019 Oct; 134(14):1132-1143. PubMed ID: 31292114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell prolymphocytic leukemia frequently shows cutaneous involvement and is associated with gains of MYC, loss of ATM, and TCL1A rearrangement.
    Hsi AC; Robirds DH; Luo J; Kreisel FH; Frater JL; Nguyen TT
    Am J Surg Pathol; 2014 Nov; 38(11):1468-83. PubMed ID: 25310835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolving management of a rare lymphoproliferative disorder-T-cell prolymphocytic leukemia.
    Gallipoli P; Clark A; Leach M
    Am J Hematol; 2009 Nov; 84(11):750-3. PubMed ID: 19714590
    [No Abstract]   [Full Text] [Related]  

  • 16. A new case of Sézary cell leukemia: a morphological variant of prolymphocytic leukemia.
    Pérez-Vila Mf; Espinet B; Solé F; Pedro C; Woessner S; Florensa L
    Haematologica; 2000 Jul; 85(7):775-6. PubMed ID: 10897140
    [No Abstract]   [Full Text] [Related]  

  • 17. Laboratory diagnosis of large granular lymphocytic leukemia.
    Lima M
    Lab Hematol; 2004; 10(3):148-9. PubMed ID: 15529425
    [No Abstract]   [Full Text] [Related]  

  • 18. Polytypic T-cell prolymphocytic leukemia.
    Ames E; Silva O
    Blood; 2021 Apr; 137(15):2125. PubMed ID: 33856441
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple karyotypic abnormalities in three cases of small cell variant of T-cell prolymphocytic leukemia.
    Heinonen K; Mahlamäki E; Hämäläinen E; Nousiainen T; Mononen I
    Cancer Genet Cytogenet; 1994 Nov; 78(1):28-35. PubMed ID: 7987802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell prolymphocytic leukemia in a 63-year-old female with a pre-existing T-cell large granular lymphocytic leukemia: metachronous T-cell leukemias with discordant subset restrictions (CD4 versus CD8) and distinct clonal identities.
    Wei Q; Papavassiliou P; Rehder C; Sebastian S; Wang E
    Pathol Res Pract; 2014 Dec; 210(12):1100-5. PubMed ID: 25238936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.